TW229157B - - Google Patents
Info
- Publication number
- TW229157B TW229157B TW081105603A TW81105603A TW229157B TW 229157 B TW229157 B TW 229157B TW 081105603 A TW081105603 A TW 081105603A TW 81105603 A TW81105603 A TW 81105603A TW 229157 B TW229157 B TW 229157B
- Authority
- TW
- Taiwan
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16258791 | 1991-07-03 | ||
| JP3346992 | 1992-02-20 | ||
| JP4571892 | 1992-03-03 | ||
| JP10058592 | 1992-03-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW229157B true TW229157B (enExample) | 1994-09-01 |
Family
ID=27459795
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW081105603A TW229157B (enExample) | 1991-07-03 | 1992-07-15 |
Country Status (11)
| Country | Link |
|---|---|
| US (5) | US5672603A (enExample) |
| EP (1) | EP0552373B1 (enExample) |
| KR (1) | KR100196368B1 (enExample) |
| AU (1) | AU648690B2 (enExample) |
| CA (1) | CA2090876A1 (enExample) |
| DE (1) | DE69230131T2 (enExample) |
| DK (1) | DK0552373T3 (enExample) |
| ES (1) | ES2138971T3 (enExample) |
| MX (1) | MX9203950A (enExample) |
| TW (1) | TW229157B (enExample) |
| WO (1) | WO1993000902A1 (enExample) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2121148A1 (en) * | 1992-08-19 | 1994-03-03 | Satoru Nakai | Apoptosis regulator |
| CA2134880A1 (en) * | 1993-03-02 | 1994-09-03 | Akira Matsumori | Graft rejection inhibitor and il-1 production inhibitor |
| GB9311132D0 (en) * | 1993-05-28 | 1993-07-14 | Eisai London Res Lab Ltd | Control of cell death |
| DK0674515T3 (da) * | 1993-10-21 | 1999-12-20 | Otsuka Pharma Co Ltd | Anvendelse af carbostyrilderivater til fremstilling af et medikament til inhibering af interleukin-8 |
| US5504093A (en) * | 1994-08-01 | 1996-04-02 | Otsuka Pharmaceutical Co., Ltd. | Method for inhibiting nucleoside and nucleobase transport in mammalian cells, and method for inhibition of DNA virus replication |
| CN1143322A (zh) * | 1995-01-11 | 1997-02-19 | 大冢制药株式会社 | 调节细胞程序死亡的药物组合物 |
| WO1998046229A1 (en) * | 1995-06-21 | 1998-10-22 | Otsuka Pharmaceutical Co., Ltd. | Il-8 and mcaf production inhibitors |
| JPH0971532A (ja) * | 1995-09-06 | 1997-03-18 | Otsuka Pharmaceut Co Ltd | 発癌抑制剤 |
| US5700803A (en) * | 1995-12-12 | 1997-12-23 | Otsuka Pharmaceutical Co., Ltd. | Method for reducing infarct size in subjects afflicted with ischemic heart disease |
| AU6854398A (en) * | 1997-04-25 | 1998-11-24 | Otsuka Pharmaceutical Co., Ltd. | Hyaluronate synthesis inhibitors |
| US6008209A (en) * | 1997-04-28 | 1999-12-28 | Hoffmann-La Roche Inc. | Method of using vitamin D3 analogs with bis C-20 side chains |
| WO1999015179A1 (en) * | 1997-09-25 | 1999-04-01 | Regents Of The University Of Minnesota | Methods of limiting apoptosis of cells |
| US6281191B1 (en) | 1997-12-29 | 2001-08-28 | Vladimir I. Slesarev | Compositions and methods for treating hepatitis-C |
| FR2774289B1 (fr) * | 1998-02-03 | 2002-05-24 | Goemar Lab Sa | Medicament pour le traitement des dereglements de l'apoptose |
| BR9911882A (pt) | 1998-07-13 | 2005-02-15 | Univ Texas | Processo de tratamento de câncer empregando anticorpos a aminofosfolipìdios |
| SI1107795T1 (en) | 1998-09-04 | 2003-06-30 | The Regents Of The University Of Michigan | Thiomolybdate associated with at least one carbohydrate, and its use for preventing or treating diseases characterized by aberrant vascularization, such as cancer, wet type macular degeneration, rheumatoid arthritis |
| US6277974B1 (en) | 1999-12-14 | 2001-08-21 | Cogent Neuroscience, Inc. | Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death |
| US20030044413A1 (en) * | 2000-08-15 | 2003-03-06 | Regents Of The University Of Minnesota | Methods of limiting apoptosis of cells |
| US20050107451A1 (en) * | 2001-12-20 | 2005-05-19 | Portbury Stuart D. | Methods for treating conditions, disorders, or diseases involving cell death |
| NZ574146A (en) | 2002-07-15 | 2010-05-28 | Univ Texas | Peptides binding to phosphatidylethanolamine and their use in treating viral infections |
| KR20050103185A (ko) * | 2002-11-07 | 2005-10-27 | 리전츠 오브 더 유니버스티 오브 미네소타 | 출혈과 관련된 신경계 손상의 치료 방법 |
| US8431396B2 (en) | 2003-03-21 | 2013-04-30 | The Cleveland Clinic Foundation | Anti-angiogenic peptides |
| US20060204481A1 (en) * | 2003-04-02 | 2006-09-14 | Steer Clifford J | Methods of promoting cell viability |
| BRPI0507039A8 (pt) | 2004-01-22 | 2018-12-18 | Univ Miami | composição, métodos de tratar um paciente com câncer, e de inibir a angiogênese em um tumor, e, kit |
| EP1871385A1 (en) * | 2005-02-10 | 2008-01-02 | Regents Of The University Of Minnesota | Methods for treating visual disorders |
| EA034136B1 (ru) | 2007-11-09 | 2020-01-09 | Перигрин Фармасьютикалз, Инк. | Изолированное антитело, которое связывается с vegf, и его применения |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5430184A (en) * | 1977-08-10 | 1979-03-06 | Otsuka Pharmaceut Co Ltd | 3,4-dihydrocarbostyril derivative |
| JPS6038384B2 (ja) * | 1978-03-24 | 1985-08-31 | 大塚製薬株式会社 | チオセミカルバゾン誘導体 |
| JPS5777676A (en) * | 1980-10-31 | 1982-05-15 | Otsuka Pharmaceut Co Ltd | Carbostyril derivative |
| JPS5793962A (en) * | 1980-12-01 | 1982-06-11 | Otsuka Pharmaceut Co Ltd | Carbostyryl derivative |
| JPS62135423A (ja) * | 1985-12-09 | 1987-06-18 | Otsuka Pharmaceut Co Ltd | 低酸素症改善剤 |
-
1992
- 1992-07-02 ES ES92914177T patent/ES2138971T3/es not_active Expired - Lifetime
- 1992-07-02 EP EP92914177A patent/EP0552373B1/en not_active Expired - Lifetime
- 1992-07-02 AU AU22317/92A patent/AU648690B2/en not_active Ceased
- 1992-07-02 DE DE69230131T patent/DE69230131T2/de not_active Expired - Fee Related
- 1992-07-02 KR KR1019930700644A patent/KR100196368B1/ko not_active Expired - Fee Related
- 1992-07-02 WO PCT/JP1992/000841 patent/WO1993000902A1/ja not_active Ceased
- 1992-07-02 CA CA002090876A patent/CA2090876A1/en not_active Abandoned
- 1992-07-02 DK DK92914177T patent/DK0552373T3/da active
- 1992-07-03 MX MX9203950A patent/MX9203950A/es unknown
- 1992-07-15 TW TW081105603A patent/TW229157B/zh active
-
1995
- 1995-06-06 US US08/466,449 patent/US5672603A/en not_active Expired - Fee Related
-
1997
- 1997-05-09 US US08/853,746 patent/US5798358A/en not_active Expired - Fee Related
- 1997-05-09 US US08/854,073 patent/US5916890A/en not_active Expired - Fee Related
- 1997-05-09 US US08/854,074 patent/US5872120A/en not_active Expired - Fee Related
- 1997-05-09 US US08/853,745 patent/US5925640A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| HK1004469A1 (en) | 1998-11-27 |
| EP0552373B1 (en) | 1999-10-13 |
| EP0552373A1 (en) | 1993-07-28 |
| US5925640A (en) | 1999-07-20 |
| US5916890A (en) | 1999-06-29 |
| AU648690B2 (en) | 1994-04-28 |
| AU2231792A (en) | 1993-02-11 |
| EP0552373A4 (en) | 1993-09-22 |
| US5798358A (en) | 1998-08-25 |
| DK0552373T3 (da) | 1999-12-27 |
| KR100196368B1 (ko) | 1999-06-15 |
| DE69230131D1 (de) | 1999-11-18 |
| ES2138971T3 (es) | 2000-02-01 |
| DE69230131T2 (de) | 2000-03-02 |
| KR930702002A (ko) | 1993-09-08 |
| WO1993000902A1 (fr) | 1993-01-21 |
| US5672603A (en) | 1997-09-30 |
| US5872120A (en) | 1999-02-16 |
| CA2090876A1 (en) | 1993-01-04 |
| MX9203950A (es) | 1993-05-01 |